Previous Article | Next Article 
Journal of Virology, June 2005, p. 7300-7310, Vol. 79, No. 12
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.12.7300-7310.2005
Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus
Claire Y.-H. Huang,*
Shawn J. Silengo,
Melissa C. Whiteman, and
Richard M. Kinney
Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Fort Collins, Colorado
Received 28 October 2004/
Accepted 14 February 2005
Chimeric dengue serotype 2/West Nile (D2/WN) viruses expressing prM-E of WN NY99 virus in the genetic background of wild-type D2 16681 virus and two candidate D2 PDK-53 vaccine variants (PDK53-E and PDK53-V) were engineered. The viability of the D2/WN viruses required incorporation of the WN virus-specific signal sequence for prM. Introduction of two mutations at M-58 and E-191 in the chimeric cDNA clones further improved the viability of the chimeras constructed in all three D2 carriers. Two D2/WN chimeras (D2/WN-E2 and -V2) engineered in the backbone of the PDK53-E and -V viruses retained all of the PDK-53 vaccine characteristic phenotypic markers of attenuation and were immunogenic in mice and protected mice from a high-dose 107 PFU challenge with wild-type WN NY99 virus. This report further supports application of the genetic background of the D2 PDK-53 virus as a carrier for development of live-attenuated, chimeric flavivirus vaccines in general and the development of a chimeric D2/WN vaccine virus against WN disease in particular.
* Corresponding author. Mailing address: Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, P.O. Box 2087, Fort Collins, CO 80522. Phone: (970) 221-6433. Fax: (970) 221-6476. E-mail:
CHuang1{at}cdc.gov.
Journal of Virology, June 2005, p. 7300-7310, Vol. 79, No. 12
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.12.7300-7310.2005
This article has been cited by other articles:
-
Suzuki, R., Fayzulin, R., Frolov, I., Mason, P. W.
(2008). Identification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine Candidate. J. Virol.
82: 6942-6951
[Abstract]
[Full Text]
-
Sirigulpanit, W., Kinney, R. M., Leardkamolkarn, V.
(2007). Substitution or deletion mutations between nt 54 and 70 in the 5' non-coding region of dengue type 2 virus produce variable effects on virus viability. J. Gen. Virol.
88: 1748-1752
[Abstract]
[Full Text]
-
Chu, J.-H. J., Chiang, C.-C. S., Ng, M.-L.
(2007). Immunization of Flavivirus West Nile Recombinant Envelope Domain III Protein Induced Specific Immune Response and Protection against West Nile Virus Infection. J. Immunol.
178: 2699-2705
[Abstract]
[Full Text]
-
Choi, K.-S., Ko, Y.-J., Nah, J.-J., Kim, Y.-J., Kang, S.-Y., Yoon, K.-J., Joo, Y.-S.
(2007). Monoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse Sera. CVI
14: 134-138
[Abstract]
[Full Text]
-
Kinney, R. M., Huang, C. Y.-H., Whiteman, M. C., Bowen, R. A., Langevin, S. A., Miller, B. R., Brault, A. C.
(2006). Avian virulence and thermostable replication of the North American strain of West Nile virus. J. Gen. Virol.
87: 3611-3622
[Abstract]
[Full Text]
-
Calvert, A. E., Huang, C. Y.-H., Kinney, R. M., Roehrig, J. T.
(2006). Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol.
87: 339-346
[Abstract]
[Full Text]